Cite
Inhibition of protein kinase C-driven nuclear factor-kappaB activation: synthesis, structure-activity relationship, and pharmacological profiling of pathway specific benzimidazole probe molecules.
MLA
Peddibhotla, Satyamaheshwar, et al. “Inhibition of Protein Kinase C-Driven Nuclear Factor-KappaB Activation: Synthesis, Structure-Activity Relationship, and Pharmacological Profiling of Pathway Specific Benzimidazole Probe Molecules.” Journal of Medicinal Chemistry, vol. 53, no. 12, June 2010, pp. 4793–97. EBSCOhost, https://doi.org/10.1021/jm1000248.
APA
Peddibhotla, S., Shi, R., Khan, P., Smith, L. H., Mangravita-Novo, A., Vicchiarelli, M., Su, Y., Okolotowicz, K. J., Cashman, J. R., Reed, J. C., & Roth, G. P. (2010). Inhibition of protein kinase C-driven nuclear factor-kappaB activation: synthesis, structure-activity relationship, and pharmacological profiling of pathway specific benzimidazole probe molecules. Journal of Medicinal Chemistry, 53(12), 4793–4797. https://doi.org/10.1021/jm1000248
Chicago
Peddibhotla, Satyamaheshwar, Ranxin Shi, Pasha Khan, Layton H Smith, Arianna Mangravita-Novo, Michael Vicchiarelli, Ying Su, et al. 2010. “Inhibition of Protein Kinase C-Driven Nuclear Factor-KappaB Activation: Synthesis, Structure-Activity Relationship, and Pharmacological Profiling of Pathway Specific Benzimidazole Probe Molecules.” Journal of Medicinal Chemistry 53 (12): 4793–97. doi:10.1021/jm1000248.